Articles published by Summit Therapeutics
Summit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application
November 15, 2026
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.
July 14, 2026
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference
June 04, 2026
From Summit Therapeutics
Via Business Wire
Tickers
SMMT
From Summit Therapeutics
Via Business Wire
Tickers
SMMT